The relationship between atherogenic index of plasma and plaque vulnerabilities: an optical coherence tomography study

Cardiovasc DiabetolPublished Cross-sectional study

Main finding · Prevalence of thin-cap fibroatheroma (TCFA)Result — go to the resultOdds ratio 11.130 95% CI 4.186–29.593

Authors' conclusion

AIP is an independent predictor for vulnerable plaques beyond traditional factors. It can be integrated in clinical practice for risk stratification of ACS patients.

Study context

Population
Patients with acute coronary syndrome (ACS) undergoing pre-intervention optical coherence tomography (OCT), January 2016 to June 2017; Atherogenic index of plasma (AIP) = log10(TG/HDL-C)332 analysed
Participants
522 patients
Exposure
AIP quartiles
Outcome
Prevalence of thin-cap fibroatheroma (TCFA)
Methodological detailsoptical coherence tomography, pre-intervention
  • Optical coherence tomography
  • Pre-intervention

Main finding

As reported in the abstract

Odds ratio

11.130

95% CI 4.186–29.593

P < 0.001

By group

Group IVvs Group I
OR 11.130 (95% CI 4.186–29.593); P < 0.001

Observational data: associations, not effects.

Further findings

OutcomeGroup IGroup IIGroup IIIGroup IVOR (95% CI)P value
Plaque ruptureGroup IVvs Group IMultivariate logistic regression10.4%14.1%17.6%34.1%5.332 (2.040–13.937)P < 0.001

Macrophage accumulation

Plaque erosion

Plaque rupture

Significantly different among AIP quartiles

Macrophage accumulation

Significantly different among AIP quartiles

Plaque erosion

Significantly different among AIP quartiles

Predictive value (ROC) of AIP

AIP for thin-cap fibroatheroma (TCFA)
0.720
AIP for plaque rupture
0.669

Original publication

The relationship between atherogenic index of plasma and plaque vulnerabilities: an optical coherence tomography study. Cardiovasc Diabetol. Published 18 December 2024. doi:10.1186/s12933-024-02532-4

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.